Skip to main content
Top
Published in: Annals of Surgical Oncology 9/2020

01-09-2020 | Melanoma | Melanoma

Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma

Author: Georgia M. Beasley, MD MHSc

Published in: Annals of Surgical Oncology | Issue 9/2020

Login to get access

Excerpt

Acral melanoma occurs on skin with much less direct sun exposure—the soles, palms, and nail beds—compared with the skin of sun-exposed regions where other subtypes of cutaneous melanoma occur: the head, neck, truck, and extremities. Therefore, we might expect acral melanomas to have a distinct genesis and biology that may not be as directly linked to sun damage. Indeed, while ultraviolet-induced oncogenesis is predominant in cutaneous melanoma, transcriptomic and genomic analyses of acral melanoma have in fact revealed an absence of ultraviolet-derived tumorigenesis.1 Even though the molecular profile is unique, acral melanomas are currently assigned to the same stage categories and treated similarly to other subtypes of cutaneous melanomas. In this issue of Annals of Surgical Oncology, Wei et al.2 examine and compare the clinicopathological and survival profiles across primary sites in acral melanoma. These authors describe a series of over 1000 patients with acral melanoma, one of the largest series known to date. Their overall findings can help inform clinicians who take care of patients with this disease about incidence and prognosis related to acral melanoma, including prognosis by anatomic site. …
Literature
1.
go back to reference Liang WS, Hendricks W, Kiefer J, Schmidt J, Sekar S, Carpten J, Craig DW, Adkins J, Cuyugan L, Manojlovic Z, Halperin RF, Helland A, Nasser S, Legendre C, Hurley LH, Sivaprakasam K, Johnson DB, Crandall H, Busam KJ, Zismann V, Deluca V, Lee J, Sekulic A, Ariyan CE, Sosman J, Trent J: Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma. Genome Res 27:524–532, 2017PMC5378171 Liang WS, Hendricks W, Kiefer J, Schmidt J, Sekar S, Carpten J, Craig DW, Adkins J, Cuyugan L, Manojlovic Z, Halperin RF, Helland A, Nasser S, Legendre C, Hurley LH, Sivaprakasam K, Johnson DB, Crandall H, Busam KJ, Zismann V, Deluca V, Lee J, Sekulic A, Ariyan CE, Sosman J, Trent J: Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma. Genome Res 27:524–532, 2017PMC5378171
3.
go back to reference Gershenwald JE, Scolyer RA. Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond. Ann Surg Oncol 25:2105–2110, 2018 Gershenwald JE, Scolyer RA. Melanoma staging: American Joint Committee on Cancer (AJCC) 8th edition and beyond. Ann Surg Oncol 25:2105–2110, 2018
4.
go back to reference Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH: Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update. Ann Surg Oncol 25:356-377, 2018CrossRef Wong SL, Faries MB, Kennedy EB, Agarwala SS, Akhurst TJ, Ariyan C, Balch CM, Berman BS, Cochran A, Delman KA, Gorman M, Kirkwood JM, Moncrieff MD, Zager JS, Lyman GH: Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology clinical practice guideline update. Ann Surg Oncol 25:356-377, 2018CrossRef
5.
go back to reference Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307-17, 2006CrossRef Morton DL, Thompson JF, Cochran AJ, Mozzillo N, Elashoff R, Essner R, Nieweg OE, Roses DF, Hoekstra HJ, Karakousis CP, Reintgen DS, Coventry BJ, Glass EC, Wang HJ: Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355:1307-17, 2006CrossRef
6.
go back to reference Kong Y, Sheng X, Wu X, Yan J, Ma M, Yu J, Si L, Chi Z, Cui C, Dai J, Li Y, Yu H, Xu T, Tang H, Tang B, Mao L, Lian B, Wang X, Yan X, Li S, Guo J: Frequent genetic aberrations in the CDK4 pathway in acral melanoma indicate the potential for CDK4/6 inhibitors in targeted therapy. Clin Cancer Res 23:6946-6957, 2017CrossRef Kong Y, Sheng X, Wu X, Yan J, Ma M, Yu J, Si L, Chi Z, Cui C, Dai J, Li Y, Yu H, Xu T, Tang H, Tang B, Mao L, Lian B, Wang X, Yan X, Li S, Guo J: Frequent genetic aberrations in the CDK4 pathway in acral melanoma indicate the potential for CDK4/6 inhibitors in targeted therapy. Clin Cancer Res 23:6946-6957, 2017CrossRef
Metadata
Title
Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma
Author
Georgia M. Beasley, MD MHSc
Publication date
01-09-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 9/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08460-3

Other articles of this Issue 9/2020

Annals of Surgical Oncology 9/2020 Go to the issue